Pellino Gianluca, Sciaudone Guido, Candilio Giuseppe, Selvaggi Francesco
Unit of General Surgery, Second University of Naples, Naples, Italy.
Dis Colon Rectum. 2015 Aug;58(8):753-61. doi: 10.1097/DCR.0000000000000403.
Local recurrences of rectal cancer are best treated with surgical resection. Health-related quality of life is an important outcome measure in rectal cancer, but it has been poorly investigated in local recurrences.
The purpose of this study was to assess quality of life in patients receiving or not receiving surgery for locally recurrent rectal cancer.
This was a prospective cohort study.
The study was conducted at a single tertiary care institution.
Patients presenting with local recurrent rectal cancer between December 2002 and December 2011 were included. A control group of patients with nonrecurrent rectal cancer was prospectively enrolled (planned ratio, 1:2).
All of the patients received the core Quality of Life Questionnaire C30 of the European Organisation for Research and Treatment of Cancer preoperatively or at diagnosis and then 1 and 3 years later. We compared results according to oncologic clearance (R0 vs R1 vs R2 vs no surgery). Confounding variables were tested with a multivariate logistic regression.
Forty-five patients (27 men), median age 62 years (range, 34-80 years), with recurrence were observed. Twelve (26.7%) were not fit for surgery. Twenty one (63.6%), 7 (21.2%), and 5 (15.2%) received R0, R1, and R2 resections. Data for 30 (90.9%) and 25 operated patients (75.75%) were available at 1- and 3-year follow-ups. Irrespective of type of surgery and multimodal treatments, patients receiving R0/R1 resections had improvement in quality of life in all of the domains compared with the R2 and no-surgery groups. Outcomes were inferior compared with nonrecurrent control subjects (N = 71). At 3 years, R0 patients reported scores equal to those of control subjects, with superior emotional functioning. R1 patients had worse symptoms and quality of life at 3-year follow-up. Surgery impaired survival and quality of life of R2 patients compared with those who were not operated on.
The study was limited because it involved a single center with a single senior surgeon.
Quality of life of patients with locally recurrent rectal cancer is improved by R0 and ameliorated with R1 resection, irrespective of surgical extent. Full recovery, similar to that of nonrecurrent cancer survivors, can be expected in R0 patients but requires longer follow-up times. Surgery with macroscopic involvement of resection margins accelerates quality of life decline and shortens survival.
直肠癌局部复发最好通过手术切除治疗。健康相关生活质量是直肠癌的一项重要结局指标,但在局部复发方面的研究较少。
本研究旨在评估接受或未接受局部复发性直肠癌手术患者的生活质量。
这是一项前瞻性队列研究。
研究在一家三级医疗机构进行。
纳入2002年12月至2011年12月间出现局部复发性直肠癌的患者。前瞻性纳入一组非复发性直肠癌患者作为对照组(计划比例为1:2)。
所有患者在术前或诊断时以及之后1年和3年接受欧洲癌症研究与治疗组织的核心生活质量问卷C30调查。我们根据肿瘤切除情况(R0 vs R1 vs R2 vs未手术)比较结果。使用多因素逻辑回归分析混杂变量。
观察到45例复发患者(27例男性),中位年龄62岁(范围34 - 80岁)。12例(26.7%)不适合手术。21例(63.6%)、7例(21.2%)和5例(15.2%)分别接受了R0、R1和R2切除。在1年和3年随访时分别有30例(90.9%)和25例手术患者(75.75%)的数据可用。无论手术类型和多模式治疗如何,与R2组和未手术组相比,接受R0/R1切除的患者在所有领域的生活质量均有所改善。与非复发对照组(N = 71)相比,结局较差。在3年时,R0患者报告的得分与对照组相当,情绪功能更佳。R1患者在3年随访时症状和生活质量较差。与未手术患者相比,手术损害了R2患者的生存和生活质量。
本研究存在局限性,因为它涉及一个单一中心且由一位资深外科医生操作。
无论手术范围如何,R0切除可改善局部复发性直肠癌患者的生活质量,R1切除可使其有所改善。R0患者有望完全康复,类似于非复发癌症幸存者,但需要更长的随访时间。切除边缘有肉眼可见受累的手术会加速生活质量下降并缩短生存时间。